Scopus Biopharma Alpha and Beta Analysis
| SCPSDelisted Stock | USD 0.10 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Scopus Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Scopus Biopharma over a specified time horizon. Remember, high Scopus Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Scopus Biopharma's market risk premium analysis include:
Beta (1.30) | Alpha 0.45 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Scopus |
Scopus Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Scopus Biopharma market risk premium is the additional return an investor will receive from holding Scopus Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Scopus Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Scopus Biopharma's performance over market.| α | 0.45 | β | -1.3 |
Scopus Biopharma Fundamentals Vs Peers
Comparing Scopus Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Scopus Biopharma's direct or indirect competition across all of the common fundamentals between Scopus Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Scopus Biopharma or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Scopus Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Scopus Biopharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Scopus Biopharma to competition |
| Fundamentals | Scopus Biopharma | Peer Average |
| Return On Equity | -15.6 | -0.31 |
| Return On Asset | -4.61 | -0.14 |
| Current Valuation | 1.18 M | 16.62 B |
| Shares Outstanding | 21.09 M | 571.82 M |
| Shares Owned By Insiders | 50.66 % | 10.09 % |
| Shares Owned By Institutions | 2.15 % | 39.21 % |
| Number Of Shares Shorted | 23.77 K | 4.71 M |
Scopus Biopharma Opportunities
Scopus Biopharma Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Scopus Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Scopus or other otcs. Alpha measures the amount that position in Scopus Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Scopus Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Scopus Biopharma's short interest history, or implied volatility extrapolated from Scopus Biopharma options trading.
Build Portfolio with Scopus Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Scopus OTC Stock
If you are still planning to invest in Scopus Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scopus Biopharma's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Correlations Find global opportunities by holding instruments from different markets |